In our ongoing project to catch up with last year’s TR35, we sat down with Shiladitya Sengupta, now an assistant professor in the Harvard-MIT Division of Health Sciences and Technology. He talked with us about how the “nanocell” cancer treatment technology that initially drew him to our attention fits in with his philosophy of using technology to solve medical problems for everyone–not just the elite. Sengupta’s passion for applying basic science to the creation of medicines that patients can actually use is unmistakable.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.